Takeda august FY25
Ended Awarded Last action
- Contract number
- 15B50925F00000236
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI DDEVYUAXJ624
- Awarding agency
-
Federal Correctional Institution Fort Worth
Correctional Facilities, Department of Justice
- Obligated
- $107,748
Award facts
- Contract value 100% obligated
- $107,748.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lexington, MA 02421, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$2,138 | |
| Original award | $109,886 |
About this award
Takeda Pharmaceuticals America Inc., a subsidiary of Japan-based Takeda Pharmaceutical Company Limited, was awarded a delivery order valued at $107,748.24 by the Federal Correctional Institution Fort Worth on August 1, 2025, with completion targeted for August 31, 2025. The award represents a firm fixed-price delivery order under the General Services Administration's Pharmaceuticals and Drugs Schedule (FSS-61-IB) and does not utilize a set-aside designation. The contract calls for delivery of specialized pharmaceutical products to the Lexington, Massachusetts location, supporting the federal correctional institution's healthcare operations.
This award is consistent with Takeda Pharmaceuticals America Inc.'s ongoing partnership with the Bureau of Prisons and other federal agencies to supply critical medications including treatments for rare diseases, hematology conditions, immunology disorders, and oncology. The company maintains a substantial Blanket Purchase Agreement with the VA National Acquisition Center valued at $131,039,520.00, effective through July 2026, which provides a streamlined procurement mechanism for advanced pharmaceutical products across multiple federal agencies. This delivery order leverages that established relationship to ensure timely access to specialized medications required for inmate healthcare and treatment programs within the federal correctional system.
Quick answers
Who was awarded contract 15B50925F00000236?
15B50925F00000236 was awarded to Takeda Pharmaceuticals America, Inc. by Federal Correctional Institution Fort Worth (Correctional Facilities) on August 1, 2025.
How much is contract 15B50925F00000236 worth?
The government has obligated $107,748 on 15B50925F00000236.
Is contract 15B50925F00000236 an order under another contract?
Yes. 15B50925F00000236 is a delivery order under V797D50492, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B50925F00000236 competed?
The extent of competition for 15B50925F00000236 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award